Case Lake project shows promise with high-grade cesium, lithium, and tantalum mineralization. See why I rate the stock a buy.

Max Helfert is a Master’s in Finance student at USC, pursuing a career in equity research. He specializes in healthcare innovation, leveraging a bottom-up approach to identify high-growth ...

Semrush Holdings basically offers an AI-enhanced SaaS platform for digital marketing. Click here to read why SEMR stock is a ...

Park Ha operates in a large, fast-growing market but faces intense competition and rising costs, impacting profitability. See ...

Puma SE is poised for a turnaround with strong growth plans in the US market and strategic athlete endorsements. Read why ...

Gorman-Rupp has grown its operations. Read why I require confirmation of growth and/or pullback in GRC share price before ...

For Q4 2024, the John Hancock U.S. Growth Fund underperformed the benchmark Russell 1000 Growth Index. Click here to read the ...

TransMedics' NOP advances organ transplantation with improved outcomes & cost reductions. See why I rate TMDX stock a strong ...

For Q4 2024, the John Hancock U.S. Global Leaders Growth fund posted a small gain that trailed the return of its benchmark ...

Rapport Therapeutics focuses on developing specific small molecule therapies for CNS diseases. Check out my recommendation ...

Tesla's deferred FSD revenue and limited Robotaxi rollout show promise, but currently lack meaningful financial impact. Read ...

The John Hancock Seaport Long/Short Fund didn’t keep pace with its benchmark, the MSCI World Index for Q4 2024. Click here to ...